Osaic Holdings
CRSP icon

Osaic Holdings’s CRISPR Therapeutics CRSP Stock Holding History

Osaic Holdings’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.34M Buy
79,501
+19,445
+32% +$1.02M 0.01% 1638
2026
Q1 		$2.86M Buy
60,056
+845
+1% +$44.6K ﹤0.01% 1787
2025
Q4 		$3.1M Buy
59,211
+3,276
+6% +$196K ﹤0.01% 1739
2025
Q3 		$3.21M Buy
55,935
+3,900
+7% +$224K ﹤0.01% 1807
2025
Q2 		$2.53M Buy
52,035
+8,372
+19% +$324K ﹤0.01% 1716
2025
Q1 		$1.49M Sell
43,663
-6,253
-13% -$265K ﹤0.01% 1901
2024
Q4 		$1.94M Sell
49,916
-34,888
-41% -$1.65M ﹤0.01% 1691
2024
Q3 		$3.98M Sell
84,804
-3,597
-4% -$183K 0.01% 1191
2024
Q2 		$4.77M Sell
88,401
-2,650
-3% -$153K 0.01% 1026
2024
Q1 		$6.2M Buy
91,051
+582
+0.6% +$41.7K 0.01% 912
2023
Q4 		$5.66M Sell
90,469
-13,052
-13% -$722K 0.01% 1102
2023
Q3 		$4.7M Buy
103,521
+18,300
+21% +$945K 0.01% 1344
2023
Q2 		$4.79M Buy
85,221
+191
+0.2% +$10.8K 0.01% 1212
2023
Q1 		$3.84M Buy
85,030
+16,115
+23% +$783K 0.01% 1341
2022
Q4 		$2.8M Buy
68,915
+17,866
+35% +$948K 0.01% 1501
2022
Q3 		$3.33M Buy
51,049
+119
+0.2% +$8.62K 0.01% 1271
2022
Q2 		$3.12M Sell
50,930
-630
-1% -$37K 0.01% 1343
2022
Q1 		$3.07M Buy
51,560
+3,461
+7% +$217K 0.01% 1573
2021
Q4 		$3.66M Buy
48,099
+6,116
+15% +$534K 0.01% 1313
2021
Q3 		$4.7M Buy
41,983
+7,020
+20% +$882K 0.01% 1097
2021
Q2 		$5.64M Buy
34,963
+4,920
+16% +$598K 0.01% 977
2021
Q1 		$3.65M Buy
30,043
+12,476
+71% +$1.88M 0.01% 1143
2020
Q4 		$2.69M Sell
17,567
-4,103
-19% -$485K 0.01% 1226
2020
Q3 		$1.81M Buy
21,670
+2,271
+12% +$201K 0.01% 1369
2020
Q2 		$1.43M Buy
19,399
+222
+1% +$13K ﹤0.01% 1480
2020
Q1 		$821K Buy
+19,177
New +$990K ﹤0.01% 1681

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Osaic Holdings's CRSP Position: Q2 2026 in Review

Osaic Holdings increased its CRISPR Therapeutics (CRSP) stake by 32% in Q2 2026, buying an estimated $1.02M and bringing the position to 79,501 shares worth $4.34M. The position accounts for 0.01% of the portfolio, ranked #1638.

Osaic Holdings first reported a position in CRSP in Q1 2020 and has held it in 26 quarters since. The position peaked at $6.2M in Q1 2024. 521 funds tracked by Wall St. Rank hold CRSP as of Q2 2026.

  • Osaic Holdings held 79,501 shares of CRISPR Therapeutics worth $4.34M as of Q2 2026.
  • Osaic Holdings bought 19,445 CRISPR Therapeutics shares in Q2 2026, an estimated $1.02M.
  • CRISPR Therapeutics made up 0.01% of Osaic Holdings's portfolio in Q2 2026, its #1638 holding.
  • Osaic Holdings first reported a position in CRISPR Therapeutics in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's CRISPR Therapeutics position peaked at $6.2M in Q1 2024.
  • 521 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.